Diffuse esophageal leiomyomatosis (DL), a benign smooth-muscle-cell tumor, is characterized by abnormal cell proliferation. DL is sometimes associated with Xlinked Alport syndrome (AS), an inherited nephropathy caused by COL4A5 gene mutations. COL4A5 is tightly linked, in a head-to-head fashion, to the functionally related and coordinately regulated COL4A6 gene. No X-linked AS cases are due to COL4A6 mutations, but all DL/AS cases are always associated with deletions spanning the 5 regions of the COL4A5/COL4A6 cluster. Unlike the COL4A5 breakpoints, those of COL4A6 are clustered within intron 2 of the gene. We identified a DL/AS deletion and the first characterization of the breakpoint sequences. We show that a deletion eliminates the first coding exon of COL4A5 and the first two coding exons of COL4A6. The breakpoints share the same sequence, which, in turn, is closely homologous to the consensus sequences of topoisomerases I and II. Additional DNA evidence suggested that the male patient is a somatic mosaic for the mutation. Immunohistochemical analysis using a-chain-specific monoclonal antibodies supported this conclusion, since it revealed the absence of the a5(IV) and a6(IV) collagen chains in most but not all of the basement membranes of the smoothmuscle-cell tumor. We also documented a similar segmental staining pattern in the glomerular basement membranes of the patient's kidney. This study is particularly relevant to the understanding of DL pathogenesis and its etiology.
Introduction
Diffuse esophageal leiomyomatosis (DL; OMIM 308940 [http://www3.ncbi.nlm.nih.gov:80/htbin-post/Omim/ dispmim?308940]) is a benign smooth-muscle-cell tumor characterized by diffuse proliferation of esophageal smooth-muscle cells and at times is associated with genital and/or bronchial leiomyomatosis. The DL phenotype also has been associated with Alport syndrome (AS; OMIM 301050 [http://www3.ncbi.nlm.nih.gov:80/ htbin-post/Omim/dispmim?301050]), in rare sporadic as well as familial cases (Garcia-Torres and Orozco 1993) . AS is an inherited nephropathy characterized by progressive hematuria often associated with sensorineural deafness and ocular lesions. The syndrome is inherited usually as an X-linked dominant trait or, less frequently, as an autosomal recessive trait. Since the first discovery of the molecular defect in X-linked AS, 1120 mutations have been identified in the COL4A5 gene (Knebelmann et al. 1996; Renieri et al. 1996) . COL4A5 codes for the common subunit of the type IV collagen trimers in the glomerular basement membrane. Mutations also have been reported in the genes for the a3(IV) and a4(IV) chains (COL4A3 and COL4A4, respectively) of individuals with the rare, autosomal recessive form of AS Mochizuki et al. 1994) . In contrast, no AS case with a mutant COL4A6 gene has ever been reported. Like the COL4A3/ COL4A4 pair on chromosome 2, COL4A5 and COL4A6 are tightly linked on chromosome X, in a head-to-head organization, and share the same promoter (Oohashi et al. , 1995 Sugimoto et al. 1994) .
Molecular studies recently have established a causal relationship between the DL/AS phenotype and genomic deletions extending from the 5 -end portion of COL4A5 to the 5 -end portion of COL4A6 and including the bidirectional promoter (Zhou et al. 1993) . Unlike the COL4A5 breakpoints, the positions of which varied among different patients, another breakpoint was consistently found within a relatively small segment of the ∼180-kb intervening sequence (IVS) III of COL4A6 (Kendall et al. 1997) . Interestingly, larger deletions, extending beyond exon 3 of COL4A6, did not cause DL and only caused AS (Heidet et al. 1995) . The authors therefore suggest that the IVS III deletion leads either to the generation of a truncated COL4A6 product that somehow is involved in DL pathogenesis or to the loss of a gene within COL4A6 that, presumably, regulates smooth-muscle-cell proliferation.
As a first step toward unraveling of the mechanism(s) underlying DL, the present study was designed to elucidate the composition of the deletion region of the genomic breakpoints in a DL/AS case. The results implicate the possible involvement of topoisomerase enzymes in the genomic rearrangement responsible for the DL/AS phenotype and raise the possibility that there might be a third gene in IVS III that is involved in the regulation of smooth-muscle-cell proliferation.
Patients, Material, and Methods

Patient
The patient was a 19-year-old boy who, at the age of 6 years, was diagnosed with hematuria. A kidney-biopsy specimen revealed only a mild mesangial proliferation. Samples subjected to electron microscopic analysis contained no glomeruli; therefore, ultrastructural analysis of the glomerular basement membrane could not be performed. At the age of 8 years, esophageal dysfunction manifested itself, and the patient underwent esophagogastrectomy. The histological diagnosis was DL associated with AS. The patient's renal function had gradually worsened. There is no history of hematuria or esophageal tumors in the patient's family.
White Blood Cells and Southern Blot Analysis
Total genomic DNA was extracted and purified from peripheral white blood cells of the patient and was used for Southern blot analysis. No samples were available from the patient's parents. Some of the peripheral white blood cells of the patient were used to establish EpsteinBarr-virus-derived lymphoblastoid cell lines, in accordance with the study by Maddalena et al. (1988) . Southern blot hybridizations were performed by following routine protocols (Sambrook et al. 1989 ). Likewise, a commercially available EMBL3 human genomic library (HL1111J and HL1006dn; Clontech) was screened, and the resultant positive clones were purified and characterized in accordance with standard procedures (Sambrook et al. 1989) .
PCR Amplification
The patient's genomic DNA was amplified with primers SK F2 (5 -ATA TAG CTG GAA AAG TGT GC-3 ) and YU20E1.8R1 (5 -TAA CTG GGA AAT GTC AGA TAA C-3 ). To make the 260-bp probe 2 ( fig. 1B ), we designed a 5 primer (5 -GGA CAC ACA CCA TGA CAT GG-3 ) and a 3 primer (5 -ACC TGC GAA ACC ATC ACA AC-3 ). The reaction was performed by use of 50 ng genomic DNA, 0.5 mM each primer, 0.8 mM dNTPs, 1.5 mM Mg(OAc) 2 , 0.5 U rTth polymerase XL, and 1 # XL buffer (Perkin Elmer), in a total volume of 25 ml. The PCR conditions were as follows: denaturation at 94ЊC for 1 min and 30 cycles of 94ЊC for 30 s, 58ЊC for 1 min, and 72ЊC for 3 min, with a final elongation at 72ЊC for 10 min. PCR products were subcloned in TA vectors (Invitrogen) and were sequenced with an ABI 373S automatic sequencer (Central Research Laboratory, Okayama University Medical School). Additional oligonucleotides were synthesized for the subcloning and sequencing of the deletion junction.
Immunohistochemical Staining
Normal portions of the esophagus were obtained from an 80-year-old patient with stomach cancer, and normal portions of kidney tissues were obtained from a 70-yearold patient with renal cancer. Esophageal tumor samples from the DL/AS patient were fixed in formaldehyde and were embedded in paraffin. Previously established monoclonal antibodies specific for the six a(IV) chains were used for differential staining . Each sample was deparaffinized and stained under several conditions, as described below. Since fresh renal sections were not available, paraffin-embedded sections were used for the analysis of type IV collagen chains. Accordingly, the paraffin-embedded sections were subjected to an antigen-retrieval procedure (Shin et al. 1991) . In brief, sections were dipped in 0.2 M HCl (pH 0.9) and then were heated in a small autoclave (KT2322; ALP Co., Ltd.), at different temperatures, for 6 min. The suitable temperature for autoclaving was established empirically for each specimen and basement membrane (Naito et al. 1996) . Optimal treatment for the kidney sections was at 110ЊC for 6 min, whereas that for the esophageal tumors was at 121ЊC or 127ЊC. After antigen retrieval, the paraffin-embedded sections were incubated with antibodies, at room temperature, for 60 min. After washing with phosphate-buffered saline, the antibodies were detected with a Labeled Streptavidin-biotinin kit (DAKO Co.).
Figure 1
Relative location of the three genomic DNA fragments (A), and restriction map of genomic DNA of the normal allele and the patient's mutant allele (B). The relative location of the three overlapping clones is shown, and representative restriction sites are indicated by uppercase letters: E ϭ EcoRI; S ϭ SalI; X ϭ XhoI; B ϭ BamHI; K ϭ KpnI; A ϭ ApaI; and P ϭ PstI. Uppercase letters within parentheses indicate cloning sites. Uppercase letters with an asterisk (*) indicate the restriction sites that were estimated by genomic Southern hybridization. The name of each clone is given under the clone, and the numbers within parentheses indicate the size of each clone. Restriction sites of the normal allele (B) are drawn in correspondence with the three isolated clones. As indicated, the two genes, COL4A5 and COL4A6, are closely located and are arranged head to head. Exons 1 and 1 of the COL4A6 gene are used alternatively . For better understanding, only COL4A6 introns are indicated, as IVS I, II, and III. Blackened and unblackened boxes indicate exons, with the exon number given above the box. Several characteristic elements (i.e., L1, Alu, and the MER19 homologous sequence) are indicated by different types of boxes (Scott et al. 1987; Britten et al. 1988; Kaplan et al. 1991) . The location of the 17-kb deletion is indicated on both the normal and the mutant alleles. Probes 1 and 2, used for the genomic Southern hybridization ( fig. 2) , and the two PCR primers are shown by blackened bars and by the two small arrows, respectively.
Results
Identification of the DL/AS Deletion and Evidence for Mosaicism
Since all DL/AS cases reported to date have a deletion of the first three exons (1 , 1, and 2) of COL4A6, we isolated overlapping genomic clones from this region, for detailed analysis of our patient. These were obtained after screening a library containing normal human DNA, with the sense COL4A6 cDNA. After isolation of the first positive clone (AF2; fig. 1A ), the screen was repeated with AF2 end probes, resulting in the identification of two additional recombinants (YU19 and YU20; fig. 1A ). Together, they extended for 130 kb of DNA, from IVS I of COL4A5 to IVS III of COL4A6 (fig. 1B) .
A 1.8-kb genomic probe corresponding to the 5 segment of IVS III of COL4A6 (probe 1; fig. 1B ) was used in the Southern analysis of the patient's DNA digested with BamHI. On the basis of the restriction map of the genomic clones, the expected size of the normal allele was 23 kb (fig. 1B) . Consistent with this prediction, a single band of 23 kb was seen in the control samples, prepared from an unaffected male ( fig. 2A, lane 2) and an unaffected female ( fig. 2A, lane 3) , with the intensity of the former noticeably weaker than that of the latter. In contrast, a new and smaller band of ∼6 kb was noted for the patient's DNA ( fig. 2A, lane 1) . The opposite size differences were observed with PstI-digested DNA hybridized to the same probe (data not shown). When considered together, the results suggested a 17-kb deletion extending from 3 of the third PstI site of IVS III of COL4A6 to immediately 5 of the BamHI site of IVS I of COL4A5 (fig. 1B) .
Interestingly, both the BamHI ( fig. 2A ) and PstI (data 
Figure 3
Results of PCR amplification of the junctional fragment from DNA of the DL/AS patient. Lane 1, l HindIII size markers. Lane 2, Normal control DNA used as a template. Lane 3, DL/AS patient's DNA from peripheral white blood cells used as a template. Note that the amplified band from the two primers, SK F2 and YU20E1.8R1, was 3.2 kb. This fragment was subcloned, and the nucleotide sequence was determined. The relative locations of the primers and the amplified fragment are indicated in figure 1B . not shown) digests of the DL/AS sample also displayed the bands corresponding to the normal allele. The identical finding was noted when EcoRI-digested DNA from the patient's peripheral blood was hybridized to a probe corresponding to the 5 portion of IVS I of COL4A5 (probe 2; fig. 2B ). However, in all samples, the so-called mutant-allele band was consistently darker than the socalled normal-allele band, thus raising the possibility of somatic mosaicism.
Characterization of the Deletion Breakpoints
The results described above suggest that the DL/AS mutation is within the 23-kb BamHI fragment of the normal allele ( fig. 1B) . Thus, we next focused on determining the nucleotide sequences around the presumptive breakpoints, one around the BamHI site near probe 2 and the other around the PstI and EcoRI sites near probe 1. To determine these sequences, two primers were designed to verify the deletion, by PCR amplification of genomic DNA. Consistent with our prediction that only the mutant allele would amplify, only the mutant 3.2-kb PCR product was obtained after amplification of DNA from the patient's peripheral blood ( fig. 3 ). This product was sequenced in its entirety and was compared with the respective segments of the COL4A5 and COL4A6 genes.
The comparison demonstrated that the COL4A5 side of the breakpoint resides within the L1 transposable element (as mentioned below) and that the COL4A6 side is at nucleotides 3570-3576 of IVS III of the COL4A6 gene. Therefore, the deletion includes 12 kb of intron 1, exon 1 of COL4A5, the bidirectional promoter, and from exon 1 to 3 kb within IVS III of COL4A6 (see fig.  1B ). Nucleotide-sequence alignment around the breakpoints showed that they display CATCATC junctional homology (fig. 4) . Interestingly, the breakpoints have six topoisomerase I consensus sequences on both strands. The COL4A6 breakpoint also exhibits a 90% match to the topoisomerase II consensus sequence. A 6-bp direct repeat, AAATGC, and a sequence homologous to Alu also were located near both the COL4A5 and COL4A6 breakpoints. There was no nucleotide insertion or deletion in the junctional fragment.
Mosaic Loss of Normal Basement-Membrane Architecture
In order to relate the genotypic findings to the patient's phenotype, we immunohistochemically analyzed the basement membranes surrounding the smooth-muscle cells at the lower esophageal region and those of kidney glomeruli, using antibodies for each of the type IV collagen chains. The esophageal sample from an unaffected individual showed positive staining with monoclonal antibodies specific for the a1(IV), a2(IV), a5(IV), and a6(IV) chains ( fig. 5A , B, E, and F, respectively). As was expected, antibodies against the a3(IV) and a4(IV) chains did not show any positive signals in this tissue ( fig. 5C and D, respectively) . In the DL/AS sample, the same antibodies visualized the a1(IV) and a2(IV) chains ( fig. 5G and H, respectively) and failed to do so with
Figure 4
Nucleotide sequences of normal and mutant alleles, at the breakpoints. The relative location of the 17-kb deletion is shown in figure 1B . Nucleotide sequences of part of intron 1 of COL4A5 (top), part of IVS III of COL4A6 of the normal allele, across the breakpoints (bottom), and the corresponding region from the mutant allele in one strand (middle) are aligned. The asterisks (*) indicate the nucleotide matches. Note that the COL4A5 intron 1 sequence and the mutant-allele sequence match completely up to the central CATCATC sequence. The 3 side of the CATCATC sequence of the mutant allele and the COL4A6 IVS III sequence are also the same. Short and long arrows indicate the consensus sequences of topoisomerase I (5 -A/T-G/C-T/A-T-3 ) (Been et al. 1984) (Spitzner and Muller 1988) , respectively. Underlined sequences indicate the 6-bp direct repeat. Shaded letters and lowercase letters represent the L1 sequence and the sequence homologous to Alu, respectively. the a3(IV) and a4(IV) chains ( fig. 5I and J, respectively) . However, the expression patterns of the a5(IV) and a6(IV) chains were significantly different from those of the control samples. With the exception of a few smoothmuscle cells, most of the basement membranes were unreactive with these two antibodies ( fig. 5K and L) . Aside from differing from the normal pattern, the uneven distribution of the a5 and a6 epitopes in the DL/AS sample indirectly supports the DNA evidence for somatic mosaicism of the COL4A5/COL4A6 deletion.
and topoisomerase II (5 -A/G-N-T/C-NNCNNG-T/C-NG-G/T-TN-T/C-N-T/C-3 )
In a normal kidney-cortex sample, the a1(IV) and a2(IV) chains in all basement membranes were stained ( fig. 5M and N, respectively) . Likewise, the a3(IV), a4(IV), and a5(IV) chains showed the same positive expression pattern in glomerular basement membranes and in some parts of the tubular basement membranes ( fig.  5O , P, and Q, respectively). Consistent with our previous data, anti-a6(IV) did not show any positive staining with glomerular basement membranes but did so with some tubular and the Bowman basement membranes ( fig. 5R) . In the patient's sample, the expression patterns of the a1(IV) and a2(IV) chains were the same as those in normal tissue ( fig. 5S and T, respectively). However, the staining patterns of the a3(IV), a4(IV), and a5(IV) chains in glomerular basement membranes were segmental ( fig. 5U , V, and W, respectively). A similar discontinuous pattern was observed for the a6(IV) antibody, in the Bowman and in some tubular basement membranes ( fig. 5X) . Hence, the affected tissues of the DL/AS patient displayed a pathology consistent with the loss of COL4A5 and COL4A6 gene products in most, but not all, the cells.
Discussion
Deletions are a common type of mutation found in many organisms. The characterization of a deletion consisting of the juxtaposition of noncontiguous sequences as a result of the breaking and rejoining of the DNA strands provides an excellent opportunity to study the mechanisms that are involved in the generation of mutations in the mammalian genome. A previous report involved the partial characterization of the deletions for DL/AS (Heidet et al. 1995) . However, in this paper, we have reported the first detailed analysis of a 17-kb deletion that included the upstream regions of both the COL4A5 and COL4A6 genes and the presumptive common promoter region for both genes, from a case of DL/ AS. The deletion encompassing the two collagen genes caused two disease states, DL and AS, although one of the genes, COL4A5, is already known to be linked to AS.
It has been postulated that topoisomerases I and II may be involved in recombinational events, since these enzymes form covalent linkages in both strands of the DNA helix and can cause a single-strand break and a transient double-strand break in the helix (Bae et al. 1988; Champoux and Bullock 1988) . Hu et al. (1991) suggested that the enzymes are able to cleave DNA strands, during duplication of the dystrophin gene, and several investigations have reported that topoisomerase I and II sites were found at the breakpoints of translocations or deletions in the dystrophin and steroid sulfatase genes (Shapiro et al. 1989; Bodrug et al. 1991; van Bakel et al. 1995) . In the DL/AS case, the consensus sequences of topoisomerase I and II binding sites were found at the breakpoints. In particular, six topoisomerase I consensus sequences existed on both strands, in the CATCATC junctional homologous sequence. These results suggest that topoisomerase I and II activity may be involved in the mechanisms of DNA breakage and reunion.
The common mechanism involved in large gene deletions is recombination. There are two types of recombination events: one is the homologous unequal recombination between gene sequences or between repetitive sequence elements, and the other is nonhomologous recombination between DNA sequences with short ho-
Figure 5
Distribution of a(IV) chains in esophageal smooth muscles and kidney from a normal control and from the DL/AS patient. a(IV)-Chain-specific monoclonal antibodies (H11, H21, H31, H44, H52, and H63) were used for immunostaining. When smooth muscles in the lower esophageal region were stained, antibodies against a1, a2, a5, and a6 chains (A, B, E, and F, respectively), but not those against a3 and a4 chains (C and D, respectively) , showed positive signals in the basement membranes surrounding the smoothmuscle cells. However, although the expression patterns for a1, a2, a3, and a4 chains were almost the same in tumor tissues (G, H, I, and J, respectively) as in control tissues (A, B, C, and D, respectively) , most of the basement membranes around smooth-muscle cells were negative for a5 and a6 antibodies (K and L, respectively). In the normal kidney, a1 and a2 chains were coexpressed in all basement membranes (M and N, respectively), whereas a3, a4, and a5 chains were colocalized in glomerular basement membranes (O, P, and Q, respectively) , and a5 and a6 chains were coexpressed in Bowman basement membranes (Q and R, respectively). Distribution of a1 and a2 chains was the same in the patient's kidney (S and T, respectively) as in that of the control (M and N, respectively). However, a3, a4, and a5 chains showed a segmental pattern (indicated by arrows) in glomerular basement membranes (U, V, and W, respectively). In Bowman capsule and tubular basement membranes, the a6 chain showed a discontinuous pattern (X, between the two small arrows).
mology (Cooper and Krawczak 1993) . Efstratiadis et al. (1980) reported that, in eukaryotic genes, short direct repeats are involved in the generation of deletions by slipped mispairing during DNA replication. Nonhomologous recombination could cause large DNA rearrangements (Albertini et al. 1982) . In the b-globin gene of HPFH-2 (hereditary persistence of fetal hemoglobin), a short direct repeat was observed at the junctions of a 1100-kb deletion (Henthorn et al. 1990 ). The deletion of the COL4A5 and COL4A6 genes presented here could have involved the short repeat sequence CAT-CATC, located only at both breakpoints. Nicked or gapped breakpoints caused by topoisomerase I and II could contribute to a single-strand loop excision during slipped mispairing.
Another interesting finding was that the breakpoint on the COL4A5 side was located within the L1 repetitive element. Several examples of large deletions at the L1 elements have been reported, including that in the bglobin gene (Henthorn et al. 1990 ), although many more deletions through Alu repetitive elements have occurred in the genome (Ottolenghi and Giglioni 1982; Lehrman et al. 1985 Lehrman et al. , 1986 Li and Bray 1993) .
Genomic Southern analysis using DNA from peripheral white blood cells suggested somatic mosaicism. Immunohistochemical data from the basement membranes of glomeruli and of some tubules also supported this idea. Interestingly, it is the smooth-muscle cells proliferating preferentially in the esophageal region that cause the DL phenotype. This could be because the mutant cells have gained a growth abnormality, owing to the 17-kb deletion at the Xq22 region. We think that this implies the possibility that a large deletion in the COL4A6 gene, during somatic mitosis, could cause DL, even if the lesion is limited within the esophagus.
The expression of the COL4A5 and COL4A6 genes was blocked completely in most of the tumor tissues. Heidet et al. (1995 Heidet et al. ( , 1997 had detected transcription from exon 4 of the COL4A6 gene, by reverse-transcriptase PCR, and had suggested the possibility that an abnormal truncated a6(IV) chain could cause DL. However, we think it unlikely that the triple-helix collagen molecules that contain the abnormal truncated a6(IV) chains could be responsible for the pathogenesis of DL, because we could not detect, by immunohistochemical analysis, collagen molecules containing the a6(IV) chain, in most of the smooth-muscle cells of the tumor. What, then, causes DL in the cases of deletion of the upstream region of both the COL4A5 and COL4A6 genes? Since one case having a large deletion containing the entire COL4A6 gene represented only the AS and not the DL phenotype (Heidet et al. 1995) , it is not plausible that the entire loss of COL4A6 expression causes DL.
Our hypothesis is that a third gene and/or its regulatory elements, within the 180-kb IVS III (Kendall et al. 1997) , may regulate smooth-muscle-cell proliferation. In our DL/AS patient, the 17-kb deletion may have hit one of the regulatory elements and thus may have changed the expression of the third gene. Several AS cases that contained larger deletions, ranging from COL4A5 IVS I to COL4A6 IVS IV, did not show the DL phenotype (Heidet et al. 1995) . We think that the deletions in these AS cases all include the entire COL4A6 IVS III, which presumably contains the third gene, together with its regulatory elements, and therefore no obvious phenotypic changes were detected. A similar situation has been reported for other benign mesenchymal tumors, such as uterine leiomyoma, lipoma, and hamartoma (Schoenmakers et al. 1995) . Schoenmakers et al. demonstrated that a gene for one of the highmobility-group proteins, HMGl-C, was disrupted, and fusion transcripts were detected in several benign solid tumors, suggesting a link between a gene for a member of the high-mobility-group proteins and development of benign solid tumors. Other studies, reported by de Kok et al. (1995 Kok et al. ( , 1996 , have suggested that X-linked deafness can be caused by an 8-kb deletion ∼900 kb from the POU3F4 gene. de Kok et al. (1995 Kok et al. ( , 1996 assumed that the 8-kb region contains some cis regulatory elements (a promoter and/or an enhancer) for transcription of the gene. We also believe that the 17-kb deleted region, especially the COL4A6 IVS III, contains several essential genes and/or cis elements that could regulate smooth-muscle-cell proliferation, as mentioned above. As an approach to answer this question, gene targeting using constructs lacking the entire or a part of IVS III could be performed. However, the possibility that the truncated a6(IV) chain could cause the DL phenotype cannot be ignored (Heidet et al. 1995) . This possibility can be tested by experiments on cDNA transfection of the truncated form of the a6(IV) chain into smoothmuscle cells. 
